Synergistic OEA and BAIBA Composition for Obesity Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for obesity and related disorders such as NAFLD and NASH are inadequate due to limited efficacy and significant side effects, with a need for safe and effective therapies that can reduce body weight and improve liver function without adverse reactions.
Innovation Solution
A pharmaceutical composition comprising a synergistic combination of oleoylethanolamide (OEA) with natural β-aminoisobutyric acid (BAIBA) and antioxidants, optionally including natural Fatty Acid Amine Hydrolase Inhibitors or alpha-glucosidase inhibitors, which works by regulating appetite, enhancing fatty acid oxidation, and reducing triglyceride and cholesterol levels in the serum and liver.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current pharmacological therapies are used to treat obesity, then body weight reduction may be achieved, but significant side effects occur
Solution Approach 1:
The patent combines multiple natural compounds (OEA, BAIBA, antioxidants, FAAH inhibitors, alpha-glucosidase inhibitors) into a synergistic pharmaceutical composition. This merging of multiple active ingredients with different mechanisms of action achieves effective weight reduction while minimizing side effects associated with single-agent therapies.
Solution Approach 2:
The invention creates a composite pharmaceutical formulation containing multiple natural compounds working together. The composite nature of the composition allows for multi-target therapy addressing appetite regulation, fat oxidation, lipid metabolism, and oxidative stress simultaneously, improving efficacy while reducing harmful effects.
2Reliability
If pharmacological treatments are administered to improve liver function in NAFLD and NASH, then liver health may be enhanced, but adverse reactions occur
Solution Approach 1:
The patent utilizes natural compounds that leverage the body's own metabolic pathways to improve liver function. By using endogenous mechanisms (such as activating PPAR-alpha with OEA, inhibiting FAAH to increase endocannabinoid levels, and utilizing antioxidant pathways), the treatment converts natural physiological processes into therapeutic benefits without introducing harmful synthetic agents.
Solution Approach 2:
The pharmaceutical composition enables the body's self-healing mechanisms to improve liver function. The natural compounds work by modulating endogenous systems (lipid metabolism, oxidative stress response, inflammation pathways) rather than forcing external interventions, allowing the liver to restore function through its own regulatory capabilities.
3Object-affected harmful factors
If natural ingredients are used in the composition, then safety is improved, but manufacturing complexity increases
Solution Approach 1:
The patent divides the complex natural formulation into distinct functional modules: OEA for appetite regulation and PPAR-alpha activation, BAIBA for muscle metabolism and insulin sensitivity, antioxidants for oxidative stress protection, FAAH inhibitors for endocannabinoid modulation, and alpha-glucosidase inhibitors for carbohydrate metabolism. Each module can be separately sourced, characterized, and quality-controlled, simplifying the manufacturing of the composite natural formulation.
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
The present invention relates to a pharmaceutical composition/formulation for the prevention of diet induced obesity. More particularly, the invention relates to a composition/formulation comprising a synergistic combination of Oleoylethanolamide (OEA) and other natural ingredients can be used for treatment of obesity and its related disorders associated with fat metabolism like non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD). This can also be helpful in controlling obesity by way of maintaining body weight. The invention also provides various formulations and methods of preparing the same.